Demographical factors affecting patient compliance (Adherence) to medications in an outpatient psychiatric clinic: A preliminary study

Fabad Journal of Pharmaceutical Sciences

Volumn 28, Issue 2, 2004, Pages 77-84

  Yeǧenoǧlu, Selen ^a   Wertheimer, Albert L ^b   Dubin, William R ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b TEMPLE UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Honesty; Medication Compliance; Patient Compliance; Psychiatric Medicines

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; CITALOPRAM; CLONAZEPAM; DIAZEPAM; FLUOXETINE; GABAPENTIN; HALOPERIDOL; LORAZEPAM; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; RISPERIDONE; SEDATIVE AGENT; SERTRALINE; TEMAZEPAM; TRAZODONE; VALPROATE SEMISODIUM; VENLAFAXINE;

ADULT; AGE; AGED; ARTICLE; CAREGIVER; DEMOGRAPHY; EDUCATION; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; OUTPATIENT; PATIENT COMPLIANCE; PHARMACIST; PHYSICIAN;

EID: 2942722699     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Murphy J, Coster G. Issues in patient compliance, Drugs, 54, 797-800, 1997.
2. Ghaziuddin N, King CA, Hovey JD, Zaccagni J, Ghaziuddin M. Medication noncompliance in adolescents with psychiatric disorders, Child. Psychiatry. Hum. Dev., 30, 103-110, 1999.
3. Vanderpool HY, Weiss GB. Patient truthfulness: a test of models of the physician-patient relationship, J. Med. Philos., 9, 353-372, 1984.
4. Kroll J, Linde P, Habenicht M, Chan S, Yang M, Vang T, Souvannasoth L, Nguyen T, Ly M, Nguyen H. Medication compliance, antidepressant blood levels, and side effects in Southeast Asian patients, J. Clin. Psychopharmaco., 10, 279-283, 1990.
5. Bendtsen P, Hensing G, McKenzie L, Stridsman AK. Prescribing benzodiazepines - a critical incident study of a physician dilemma, Soc. Sci. Med., 49, 459-467, 1999.
6. Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences, Chest, (Suppl)117(2), 33-37, 2000.
7. Liam F, Stevenson FA, Britten N, Stell IM. Adherence to antibiotics prescribed in an accident and emergency department: the influence of consultation factors, Eur. J. Emerg. Med., 8, 181-188, 2001.
8. Bender B, Milgrom H, Rand CS. Nonadherence in asthmatic patients: is there a solution to the problem?, Ann. Allergy Asthma. Immunol., 79, 177-86, 1997.
9. Cheng JW, Kalis MM, Feifer S. Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Pharmacotherapy, 21, 828-841, 2001.
10. Valenstein M, Copeland LA, Owen R, Blow FC, Visnic S. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia, J. Clin. Psychiatry., 62, 545-551, 2001.
11. Ramana R, Paykel ES, Surtees PG, Melzer D, Mehta MA. Medication received by patients with depression following the acute episode: adequacy and relation to outcome, Br. J. Psychiatry, 174, 128-134, 1999.
12. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders, Psychiatr. Serv., 49, 196-201, 1998.
13. Gomes Mda M, Maia Filho Hde S. Medication-taking behavior and drug self regulation in people with epilepsy, Arq. Neuropsiquiatr, 56, 714-719, 1998.
14. Benkert O, Graf-Morgenstern M, Hillert A, Sandmann J, Ehmig SC, Weissbecker H, Kepplinger HM, Sobota K. Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection, J. Nerv. Ment. Dis., 185, 151-158, 1997.
15. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness, J. Psychosom. Res., 47, 555-567, 1999.
16. Stone VE, Hogan JW, Schuman P, Rompalo AM, Howard AA, Korkontzelou C, Smith DK. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the HER study, J. Acquir. Immune. Defic. Syndr., 28, 124-131, 2001.
17. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance, Clin. Ther., 23, 1296-1310, 2001.
18. Maixner SM, Greden JF. Extended antidepressant maintenance and discontinuation syndromes, Depress. Anxiety, 8 Suppl 1, 43-53, 1998.
19. Wertheimer AI, Smith MC (eds.). Pharmacy Practice Social and Behavioral Aspects (3rd edition). Williams & Wilkins, Maryland, 186-188, 1989.
20. Breen R, Thornhill JT. Noncompliance with medication for psychiatric disorders: reasons and remedies, CNS, Drugs, 9, 457-471, 1998.
21. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ. Predicting medication noncompliance after hospital discharge among patients with schizophrenia, Psychiatr. Serv., 51, 216-222, 2000.
22. Buck D, Jacoby A, Baker GA, Chadwick DW. Factors influencing compliance with antiepileptic drug regimes, Seizure, 6(2), 87-93, 1997.
23. Forman L. Medication: reasons and interventions for noncompliance, J. Psychosoc. Nurs. Ment. Health. Serv., 31, 23-25, 1993.
24. Marder SR. Facilitating compliance with antipsychotic medication, J. Clin. Psychiatry, 59 Suppl 3, 21-25, 1998.
25. Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs, Psychiatr. Serv., 52, 805-811, 2001.
26. Kane JM. Compliance issues in outpatient treatment, J. Clin. Psychopharmacol., 5(3 Suppl), 22S-27S, 1985.
27. Gillis LS, Trollip D, Jakoet A, Holden T. Non-compliance with psychotropic medication, S. Afr. Med. J., 72, 602-606, 1987.
28. Draine J, Solomon P. Explaining attitudes toward medication compliance among a seriously mentally ill population, J. Nerv. Ment. Dis., 182, 50-54, 1994.
29. Linden M, Godemann F, Gaebel W, Kopke W, Muller P, Muller-Spahn F, Pietzcker A, Tegeler J. A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years, Schizophr. Bull., 27, 585-596, 2001.
30. Ruscher SM, de Wit R, Mazmanian D. Psychiatric patients' attitudes about medication and factors affecting noncompliance, Psychiatr. Serv., 48, 82-85, 1997.
31. Wang PS, Gilman SE, Guardino M, Christiana JM, Morselli PL, Mickelson K, Kessler RC. Initiation of and adherence to treatment for mental disorders: examination of patient advocate group members in 11 countries, Med. Care, 38, 926-936, 2000.
32. Agarwal MR, Sharma VK, Kishore Kumar KV, Lowe D. Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors, Int. J. Soc. Psychiatry, 44, 92-106, 1998.
33. Reinken J, Sparrow M, Campbell AJ. The giving and taking of psychotropic drugs in New Zealand, N.Z. Med. J., 95, 489-492, 1982.
34. Demyttenaere K, Mesters P, Boulanger B, Dewe W, Delsemme MH, Gregoire J, Van Ganse E. Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine, J. Affect. Disord., 65, 243-252, 2001.